Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 46.21%82.29M | ---- | -32.07%56.28M | ---- | 367.18%82.85M | ---- | -138.99%-31.01M | ---- | 1,951.56%79.54M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -82.27%-17.98M | ---- | -614.27%-9.86M | ---- | -482.70%-1.38M | ---- | -35.43%-237K | ---- | -2.94%-175K | ---- |
| Attributable subsidiary (profit) loss | ---80K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | ---- | 84.17%-3.7M | ---- | -166.19%-23.4M | ---- | 1,413.48%35.36M | ---- | 60.88%2.34M | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | 84.51%-3.7M | ---- | -167.12%-23.91M | ---- | 1,606.23%35.63M | ---- | 175.10%2.09M | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | 288.56%511K | ---- | -209.27%-271K | ---- | -64.21%248K | ---- |
| Revaluation surplus: | -85.98%1.41M | ---- | 290.79%10.05M | ---- | -132.11%-5.27M | ---- | 136.25%16.41M | ---- | -26.75%-45.25M | ---- |
| -Fair value of investment properties (increase) | ---- | ---- | 293.71%10.04M | ---- | -170.95%-5.19M | ---- | 116.15%7.31M | ---- | -26.75%-45.25M | ---- |
| -Derivative financial instruments fair value (increase) | --1.73M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | -6,480.00%-319K | ---- | 106.10%5K | ---- | -100.90%-82K | ---- | --9.1M | ---- | ---- | ---- |
| Asset sale loss (gain): | 19.38%-41.92M | ---- | -293.35%-51.99M | ---- | 62.19%-13.22M | ---- | -4,155.57%-34.96M | ---- | --862K | ---- |
| -Loss (gain) from sale of subsidiary company | 62.44%-19.87M | ---- | -356.79%-52.9M | ---- | 66.87%-11.58M | ---- | -3,950.11%-34.96M | ---- | --908K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -2,528.19%-22.05M | ---- | --908K | ---- | ---- | ---- | ---- | ---- | ---46K | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---1.64M | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 34.30%190.81M | ---- | 659.95%142.08M | ---- | 100.86%18.7M | ---- | -1.21%9.31M | ---- | 171.29%9.42M | ---- |
| Financial expense | 29.54%66.56M | ---- | 103.99%51.39M | ---- | 356.34%25.19M | ---- | 61.73%5.52M | ---- | 4,390.79%3.41M | ---- |
| Special items | ---- | ---- | ---148K | ---- | ---- | ---- | ---9.17M | ---- | ---- | ---- |
| Operating profit before the change of operating capital | 44.83%281.1M | ---- | 132.52%194.09M | ---- | 1,049.51%83.47M | ---- | -117.53%-8.79M | ---- | 285.09%50.14M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -147.77%-22.12M | ---- | 126.34%46.29M | ---- | -367.98%-175.74M | ---- | ---37.55M | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | -332.35%-1.21B | ---- | 77.09%-280.83M | ---- | -546.20%-1.23B | ---- | -60.96%-189.66M | ---- | -1,145.17%-117.83M | ---- |
| Accounts payable increase (decrease) | 649.38%865.63M | ---- | -83.71%115.51M | ---- | 721.59%709.03M | ---- | -15.10%86.3M | ---- | -22.62%101.65M | ---- |
| Special items for working capital changes | 188.57%391.66M | ---- | -12.96%-442.23M | ---- | -550.01%-391.49M | ---- | 241.94%87M | ---- | -62.40%-61.29M | ---- |
| Cash from business operations | 182.28%302.11M | ---- | 63.29%-367.17M | ---- | -1,495.20%-1B | ---- | -129.43%-62.71M | ---- | -156.92%-27.33M | ---- |
| Other taxs | 42.24%-17.34M | ---- | -1,966.35%-30.02M | ---- | 71.17%-1.45M | ---- | -682.61%-5.04M | ---- | -388.79%-644K | ---- |
| Special items of business | ---- | -66.35%175.49M | ---- | 185.55%521.5M | ---- | -690.78%-609.58M | ---- | 430.97%103.18M | ---- | -416.75%-31.18M |
| Net cash from operations | 171.70%284.77M | -66.35%175.49M | 60.35%-397.19M | 185.55%521.5M | -1,378.67%-1B | -690.78%-609.58M | -142.17%-67.75M | 430.97%103.18M | -157.99%-27.98M | -416.75%-31.18M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 82.27%17.98M | ---- | 614.27%9.86M | ---- | 774.05%1.38M | ---- | 62.89%158K | ---- | -10.19%97K | ---- |
| Sale of fixed assets | 646.83%141.93M | ---- | --19M | ---- | ---- | ---- | ---- | ---- | --2.14M | ---- |
| Purchase of fixed assets | 51.13%-339.6M | ---- | 9.39%-694.88M | ---- | -877.66%-766.93M | ---- | -404.15%-78.45M | ---- | -19.66%-15.56M | ---- |
| Sale of subsidiaries | -109.84%-1.9M | ---- | 118.70%19.35M | ---- | -72.99%8.85M | ---- | 6,154.53%32.76M | ---- | ---541K | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | --8.7M | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---5.27M | ---- | ---- | ---- | ---7K | ---- | ---- | ---- | -105.02%-123.08M | ---- |
| Other items in the investment business | ---- | 153.89%337.37M | ---530K | -261.65%-625.98M | ---- | -36,187.63%-173.09M | ---- | 96.53%-477K | ---- | 58.32%-13.76M |
| Net cash from investment operations | 71.13%-186.86M | 153.89%337.37M | 13.48%-647.2M | -261.65%-625.98M | -1,542.82%-748.01M | -36,187.63%-173.09M | 66.75%-45.53M | 96.53%-477K | -70.68%-136.95M | 58.32%-13.76M |
| Net cash before financing | 109.37%97.9M | 590.85%512.86M | 40.31%-1.04B | 86.65%-104.48M | -1,444.65%-1.75B | -862.06%-782.67M | 31.31%-113.28M | 328.58%102.7M | -415.45%-164.92M | -93.97%-44.93M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 30.28%3.7B | ---- | 147.75%2.84B | ---- | 24.38%1.15B | ---- | 529.82%922.01M | ---- | --146.39M | ---- |
| Refund | -111.25%-3.45B | ---- | -727.02%-1.63B | ---- | 7.10%-197.52M | ---- | -423.23%-212.6M | ---- | ---40.63M | ---- |
| Interest paid - financing | -29.54%-66.56M | ---- | -103.99%-51.39M | ---- | -356.75%-25.19M | ---- | -61.59%-5.52M | ---- | -4,390.79%-3.41M | ---- |
| Absorb investment income | 91.13%61.93M | ---- | --32.4M | ---- | ---- | ---- | ---- | ---- | --1.26M | ---- |
| Other items of the financing business | --4K | -219.50%-658.81M | ---- | -6.64%551.29M | --385M | 668.33%590.51M | ---- | -404.28%-103.9M | 289.94%57.81M | 234.65%34.15M |
| Net cash from financing operations | -104.02%-47.69M | -219.50%-658.81M | -9.24%1.19B | -6.64%551.29M | 86.30%1.31B | 668.33%590.51M | 338.66%701.95M | -404.28%-103.9M | 615.83%160.02M | 234.65%34.15M |
| Effect of rate | 158.08%8.11M | 154.36%9.06M | 59.64%-13.97M | 58.03%-16.66M | -38.16%-34.6M | -1,048.41%-39.69M | -1,749.87%-25.05M | 751.87%4.19M | -34.37%1.52M | -688.99%-642K |
| Net Cash | -64.75%50.22M | -132.66%-145.94M | 132.23%142.48M | 332.53%446.81M | -175.09%-442.02M | -15,912.75%-192.15M | 12,108.73%588.67M | 88.87%-1.2M | 92.22%-4.9M | 77.78%-10.78M |
| Begining period cash | 93.55%265.89M | -50.99%265.89M | -77.63%137.37M | -11.64%542.53M | 1,118.90%614M | 1,118.90%614M | -6.29%50.37M | -6.29%50.37M | -53.04%53.76M | -53.04%53.76M |
| Cash at the end | 21.94%324.22M | -86.74%129M | 93.55%265.89M | 154.53%972.68M | -77.63%137.37M | 616.20%382.15M | 1,118.90%614M | 26.05%53.36M | -6.29%50.37M | -35.91%42.33M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -35.91%42.33M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.